多瑞医药拟设立西藏瑞升祥医药有限公司
DUO RUI PHARMADUO RUI PHARMA(SZ:301075) Zhi Tong Cai Jing·2025-11-07 08:13

Core Viewpoint - Duori Pharmaceutical (301075.SZ) has announced the establishment of a wholly-owned subsidiary, Tibet Ruishengxiang Pharmaceutical Co., Ltd., with a registered capital of 2 million yuan to optimize the management functions of its headquarters based on operational and strategic development needs [1] Group 1 - The company aims to enhance its management capabilities through the formation of the new subsidiary [1] - The registered capital for the new subsidiary is set at 2 million yuan [1]